1 / 28

The Patient With Difficult-to-Treat Hypercholesterolemia: Is Everything Under Control?

The Patient With Difficult-to-Treat Hypercholesterolemia: Is Everything Under Control?. LDL-C Goals. Impact of Intensive Statin Therapy on Major Vascular Events. ENHANCE: Ezetimibe Lowers LDL-C Levels but Not Progression of Atherosclerosis.

charles-crawford
Download Presentation

The Patient With Difficult-to-Treat Hypercholesterolemia: Is Everything Under Control?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Patient With Difficult-to-Treat Hypercholesterolemia: Is Everything Under Control?

  2. LDL-C Goals

  3. Impact of Intensive Statin Therapy on Major Vascular Events

  4. ENHANCE: Ezetimibe Lowers LDL-C Levels but Not Progression of Atherosclerosis

  5. IMPROVE-IT: Ezetimibe/Simvastatin Combination vs Simvastatin Monotherapy

  6. Coronary Drug Project: Niacin Associated With Reduction in Mortality in Men

  7. AIM-HIGH: Niacin Improves Lipids but Not CV Events

  8. Incidence of Muscle Adverse Effects

  9. Statins in Patients With Dementia

  10. ARIC: Reduced CHD Incidence in Individuals With PCSK9 Loss-of-Function Mutations

  11. Horus: Atherosclerosis in Ancient Egypt

  12. Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Patients With Elevated Risk (FOURIER)

  13. ODYSSEY Outcomes: Phase 3 Post-ACS With SAR236553

  14. REVEAL Trial

  15. ACCELERATE Trial

  16. Homozygous FH: Novel Treatments

  17. FH

  18. Thank you for participating in this activity

  19. Abbreviations

  20. Abbreviations (cont)

  21. References

  22. References (cont)

  23. References (Cont)

  24. References (Cont)

More Related